Why the study?
Does intravenous delta-9-tetrahydrocannabinol alter cardiac performance and systolic time intervals in healthy males with and without beta blockade?
Does intravenous delta-9-tetrahydrocannabinol alter cardiac performance and systolic time intervals in healthy males with and without beta blockade?
Answers are grounded in this paper and cite their sources.
Intravenous delta-9-THC acutely enhances cardiac performance, an effect that is partially mediated by beta-adrenergic pathways.
Systolic time intervals (STI) were measured in ten healthy male volunteers before and after intravenous (i.v.) administration of 25 mug/kg delta-9-tetrahydrocannabinol (delta-9-THC). Mean +/- SEM heart rate increased 32 +/- 7 beats/min, while systolic and diastolic blood pressures were unchanged after delta-9-THC. Total electromechanical systole lengthened 17 +/- 4.2 msec, left ventricular ejection time (LVETc) prolonged 24 +/- 4.0 msec and pre-ejection period (PEP) shortened 17 +/- 5.1 msec after delta-9-THC. All of these changes were significant (P less than 0.01). In nine other subjects who underwent prior beta adrenergic blockade, similar but less marked changes were noted in heart rate, blood pressure, and STI after delta-9-THC. The shortening of PEP after delta-9-THC was only 9 msec (NS) in beta blocked subjects. Thus, delta-9-THC significantly increased heart rate, shortened PEP and prolonged LVETc without any change in afterload. Beta adrenergic blockade prevented significant shortening of PEP and blunted other responses. These findings suggest that delta-9-THC enhanced cardiac performance. Partial inhibition of this effect was achieved with prior beta adrenergic blockade.
No takes yet. Share an insight, caveat, or question.
Kanakis et al. (1976) studied this question.
Synapse has enriched 10 related papers. Consider them for comparative context: